BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«X-Linked Lymphoproliferative

Below is an extended X-Linked Lymphoproliferative research listing. Click here to return to the X-Linked Lymphoproliferative main in depth entry.

Recent Publications on X-Linked Lymphoproliferative:

Retrovirus-induced oncogenesis and safety of retroviral vectors. 3rd October, 2008
Institute for Animal Health, Division of Microbiology, Oncogenic Virus
X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.
A major focus of our research is to understand the molecular and cellular...
Direct Link
26th September, 2008
Infectious Diseases Fellowship Training Program, Children's Hospital of
Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female.
X-linked lymphoproliferative (XLP) syndrome is a rare primary...
Direct Link
10th September, 2008
Department of Virology, LabPLUS, Auckland City Hospital, Auckland, New
Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients.
Epstein-Barr virus (EBV) persists in healthy virus carriers within the...
Direct Link
6th September, 2008
Cancer Research UK Institute for Cancer Studies, University of Birmingham,
Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).
Background Hemophagocytic lymphohistiocytosis is a life-threatening...
Direct Link
5th September, 2008
Dipartimento di Pediatria, Universita di Padova, Padova, Italy;
The adaptor 3BP2 activates CD244-mediated cytotoxicity in PKC- and SAP-dependent mechanisms.
Natural killer (NK) cell cytotoxicity requires triggering of activation...
Direct Link
3rd September, 2008
Immunoreceptors group, Institut d'Investigacio August Pi i Sunyer
The SLAM and SAP gene families control innate and adaptive immune responses.
The nine SLAM-family genes, SLAMF1-9, a subfamily of the immunoglobulin...
Direct Link
19th August, 2008
Division of Immunology, Beth Israel Deaconess Medical Center, Harvard
[The possible curative therapy for rheumatoid arthritis--EBV infection control gene SAP and its application] 14th August, 2008
Division of Hematology and Rheumatology, Department of Medicine, Nihon
Atypical lymphoproliferative disorder in a patient with X-linked thrombocytopenia.
Epstein-Barr virus (EBV) belong to herpes virus group. This virus is...
Direct Link
14th August, 2008
Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk.
Bruton's tyrosine kinase (Btk) is required for B-cell development. Btk...
Direct Link
13th August, 2008
Department of Experimental and Clinical Medicine, University of Catanzaro
Genetic defects of apoptosis and primary immunodeficiency.
Programmed cell death is important for maintaining lymphocyte homeostasis....
Direct Link
13th August, 2008
Human Immunological Diseases Unit, Laboratory of Host Defenses, National
The X-linked lymphoproliferative syndrome gene product SAP regulates B cell function through the FcgammaRIIB receptor.
X-linked lympho-proliferative (XLP) is an immunodeficiency condition...
Direct Link
30th July, 2008
Department of Biochemistry and the Siebens-Drake Research Institute,
Sequence analysis of BIRC4/XIAP in male patients with common variable immunodeficiency.
BACKGROUND: Common variable immunodeficiency (CVID) is the most common...
Direct Link
4th June, 2008
Division of Rheumatology and Clinical Immunology, Medical School,
Adolescent presentation of x-linked lymphoproliferative disease. 21st May, 2008
Immunodeficiency-associated lymphomas.
This article covers lymphoproliferative disorders in patients with primary...
Direct Link
6th May, 2008
Department of Haematology, Princess Alexandra Hospital, Ipswich Road,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional